British consumer goods major Reckitt Benckiser, which bought over local start-up Paras Pharmaceuticals for a staggering Rs 3,260 crore (Rs 32.6 billion) last year, is converting its acquired Baddi plant in Himachal Pradesh into a global hub for manufacturing over-the-counter (OTC) pharmaceutical products.
The interested companies include Emami and Dabur.
Multinational FMCG giant Reckitt Benckiser on Monday said it has agreed to fully acquire Ahmedabad -based Paras Pharmaceuticals Ltd for Rs 3,260 crore (Rs 32.60 billion).
The Mumbai-based Shah family of the diversified Anchor Group has decided to put its FMCG portfolio of oral care and personal care products on the block, according to two independent sources.
Despite slowdown, smaller firms attract growth capital.
@015 may be a good year for FMCG firms.